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Riccardo Barbieri1,7
The application of complex systems theory to physiology and medicine has provided meaningful 
information about the nonlinear aspects underlying the dynamics of a wide range of biological 
processes and their disease-related aberrations. However, no studies have investigated whether 
meaningful information can be extracted by quantifying second-order moments of time-varying 
cardiovascular complexity. To this extent, we introduce a novel mathematical framework termed 
complexity variability, in which the variance of instantaneous Lyapunov spectra estimated over time 
serves as a reference quantifier. We apply the proposed methodology to four exemplary studies 
involving disorders which stem from cardiology, neurology and psychiatry: Congestive Heart Failure 
(CHF), Major Depression Disorder (MDD), Parkinson’s Disease (PD), and Post-Traumatic Stress Disorder 
(PTSD) patients with insomnia under a yoga training regime. We show that complexity assessments 
derived from simple time-averaging are not able to discern pathology-related changes in autonomic 
control, and we demonstrate that between-group differences in measures of complexity variability are 
consistent across pathologies. Pathological states such as CHF, MDD, and PD are associated with an 
increased complexity variability when compared to healthy controls, whereas wellbeing derived from 
yoga in PTSD is associated with lower time-variance of complexity.
Physiological dynamics associated with oscillatory systems (such as the cardiovascular system) are commonly 
characterized through mathematical approaches in both the time and frequency domains. Most of these 
approaches assume intrinsic linearity and time-invariant properties. The inherent postulate is that the magnitude 
of physiological responses is proportional to the strength/amplitude of the input stimuli. Given the widespread 
accessibility of electrocardiographic (ECG) as well as pulseoximeter measurements, the analysis of Heart Rate 
Variability (HRV) has become a paradigmatic example of physiological time series analysis performed through 
linear techniques. HRV analysis is commonly based on indices such as mean heart rate, standard deviation, and 
low-frequency (LF) and high-frequency (HF) spectral powers derived from the RR interval series1. However, the 
cardiovascular system is constantly involved in a dynamical, mutual interplay with numerous other physiological 
subsystems (e.g., endocrine, neural, and respiratory), as well as in multiple self-regulating, adaptive biochemical 
processes2–4. In this context, it is well known that the effects of combined sympathetic and vagal stimulation on 
heart rate are not simply additive, as tonic sympathetic stimulation sensitizes the heart rate to vagal stimulation4. 
This is because sympathetic stimulation inhibits acetylcholine release by acting on adrenergic receptors on the 
vagal terminals, cytosolic adenosine 3,5-cyclic monophosphate mediates postjunctional interactions between the 
sympathetic and vagal systems, and acetylcholine released by vagal stimulation inhibits norepinephrine release by 
acting on muscarinic receptors on sympathetic nerve terminals. In addition, neuropeptide Y released from sym-
pathetic nerve terminals also interacts with ACh acetylcholine, and the release of neuropeptide Y is prevented by 
simultaneous vagal stimulation4. As a results, cardiovascular dynamics exhibits an inherently complex structure 
characterized by non-stationary, intermittent, scale-invariant and nonlinear behaviors1,5.
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In light of the above, methodological approaches derived from the theory of complex dynamical systems may 
provide access to a more complete description of the mechanisms underlying biological regulation of cardiac 
activity. Widely employed methods for characterizing heartbeat complexity include detrended fluctuation anal-
ysis and wavelet analysis (which quantify scaling properties, correlations, and fractal measures of variability), 
Lyapunov exponents as well as various measures of entropy such as sample entropy and its multiscale version 
(which quantify the degree of instability and predictability of the time series under investigation)6–9. The use of 
these methods has allowed improved characterization of abnormal cardiac rhythms1,10,11 and has aided in predict-
ing the risk of acute adverse events such as sudden cardiac and sudden infant death (see refs 1,9–16).
Current Limitations in Complexity Assessment
Despite the considerable achievements obtained by the measures and approaches outlined above, the application 
of these analysis strategies to physiological systems has resulted in several discrepancies in the literature. For 
example, changes in cardiovascular complexity have been observed to accompany aging17, whereas other findings 
suggest that fractal linear and nonlinear characteristics of cardiovascular dynamics do not change with age18. 
Similar controversies have been reported in the field of sleep analysis19. In this paper, we posit that these discrep-
ancies may partly be due to several methodological and applicative issues inherent to these methods, which have 
not yet been satisfactorily addressed.
First, the intrinsically discrete nature of heartbeats, which are unevenly spaced in time, often leads to the use 
of interpolation procedures, which are likely to introduce bias in the estimation of nonlinear/complexity meas-
ures. Second, traditional complexity estimation approaches/algorithms provide a single value (or set of values) 
within a predetermined time window and hence can only represent average measures of the physiological system 
dynamics observed in the entire time window. However, it is well known that physiological dynamics commonly 
undergo rapid, transient changes in time which can also occur in a number of psycho-physiological states and 
pathologic conditions20–23. In the face of non-stationary behavior, collapsing across time into a single, more or less 
representative value may not allow to capture the subtleties of complex behavior within any particular analysis 
window. Moreover, even in case of windowing strategies that would allow for the computation of more than one 
reference point estimation, this may not be sufficient to properly catch the time-varying dynamics of the com-
puted measure. Third, most of the nonlinearity and complexity measures employed to-date have been proven 
to be sensitive to the presence of uncorrelated (e.g. white) or correlated (e.g. 1/f) noise. As stochasticity plays a 
crucial role in physiological dynamics6,10, this sensitivity may lead to an overestimation of complexity which may 
become more evident in the presence of specific pathologies, such as certain cardiac arrhythmias including atrial 
fibrillation24. While when compared to healthy systems, these pathological situations appeared to be associated 
with the emergence of a more regular cardiovascular behavior(visible as a reduction in entropy)11, it was shown 
that the observed changes were due to modifications in the statistical properties of underlying physiological 
noise24.
A New Time-varying Model for Complexity Assessment
To overcome these limitations, we recently introduced novel time-varying complexity measures that can be 
applied to stochastic discrete series such as the ones related to heartbeat dynamics7,8. These novel measures are 
fully embedded in the probabilistic framework of the inhomogeneous point-process theory and are obtained by 
modeling the cardiovascular system through both deterministic and random terms. In turn, this caters for the 
simultaneous presence of both chaotic and stochastic behaviours. This idea has been successful applied in other 
studies6,25, and is in agreement with current views on the genesis and physiology of healthy heartbeat dynamics, 
which can be thought of as the output of a nonlinear deterministic system (the pacemaker cells of the sinus node) 
forced by a high-dimensional input (neural activity of fibers innervating the sinus node itself). The originality of 
the new definitions lies in the explicit mathematical formulations of the time-varying phase-space vectors, as well 
as in the definition of their distance7,8.The main advantages of these techniques are that the resulting, instanta-
neous estimates of complexity are free from bias due to either interpolation techniques or variability in statistical 
properties of noise.
Complexity Variability
Once instantaneous complexity series are available, basic time-domain features can be used to summarize cardi-
ovascular complex dynamics. In particular, measures of central tendency, e.g., the median value, and variability, 
e.g., the median absolute deviation can be calculated.
The former (central tendency) can be considered equivalent to standard complexity estimates which collapse 
data across time by design. The latter (median absolute deviation) represents an innovation in the field of com-
plexity analysis7,8, by defining a measure of complexity variability.
In this context, when adopting instantaneous Lyapunov exponents as a complexity measure7, we recently 
observed a notable (albeit preliminary) discriminant power associated with its variability. In a recent study 
on patients with congestive heart failure (CHF) and healthy subjects24 we found that neither standard sample 
(SampEn) and approximate (ApEn) entropy measures1,26 nor the median (over a given time-window) of the 
instantaneous dominant Lyapunov exponent are able to discriminate between the two populations. In contrast, 
heartbeat dynamics associated with CHF showed a significantly increased complexity variability when compared 
to healthy controls, hence providing a novel measure which could potentially aid in early discrimination and/or 
stratification of this kinds of patients27,28. Of note, these findings are in accordance with current literature indicat-
ing an effect of cardiovascular disorders on complexity and variability of biological processes29.
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Novel Definitions and Applications of Complexity Variability
In this study, we hypothesize that the discriminative potential of complexity variability measures can serve as a 
potential biomarker able to discriminate subtle changes which are not evident in other complexity measures. To 
this end, in this study we aimed to broaden the spectrum of pathologies under study to patients suffering from 
neurological and mental disorders such as major depression disorder (MDD), Post Traumatic Stress Disorders 
(PTSD), and Parkinson’s Disorders (PD). In the rest of this paper, prior art concerning cardiovascular assess-
ment of these pathologies is reported. Then, the basic mathematical formulation of inhomogeneous point-process 
models of heartbeat dynamics, as well as of instantaneous Lyapunov estimates are reported followed by experi-
mental results, discussion and conclusion.
Heartbeat Dynamics in Cardiovascular, Mental and Neurological Disorders
HRV Assessment in Congestive Heart Failure. Congestive Heart failure (CHF) is a major public health 
problem, with a prevalence of more than 5.8 million in the United States and more than 23 million worldwide30. 
HRV analysis has been previously used to discern healthy subjects from patients suffering from congestive heart 
failure (CHF)31–37. It has been accepted that linear features of heartbeat dynamics (based on spectral analysis) are 
not sufficient for CHF patient characterization, and need to be complemented by nonlinear features, ranging from 
Entropy to Non-Gaussian metrics (see refs 7,8,23,31–33,37,38 and reference therein for reviews). Also, classic 
approximate and sample entropy, as expressed in their basic form, are not able to discern between heathy subjects 
and patients with CHF8,24.
Moreover, cardiovascular dynamics in CHF patients was associated with a loss of multifractality, whose infor-
mation is encoded in the Fourier phases of HRV series23,32,33,37. Furthermore, in CHF patients, departures from 
Gaussianity have been used to evaluate increased mortality risk34,35,38.
HRV Assessment in Major Depression. According to epidemiological studies, almost 15% of the pop-
ulation in the United States has suffered from at least one episode of mood alteration39, and about 27% (equals 
82.7 million; 95% confidence interval: 78.5–87.1) of the adult European population is or has been affected by at 
least one mental disorder40. To date, biological markers, especially those derived from applying advanced signal 
processing approaches to biological signals, are not commonly incorporated in clinical routine examinations41,42. 
Previous studies have focused on depression and sleep43,44 and circadian heart rate rhythms45,46 highlighting 
autonomic changes that may be considered predictors of clinical modifications. In the realm of HRV analysis, a 
decrement of HF power and an increment of LF/HF ratio was observed in MD patients when compared to con-
trols47. However, several studies demonstrated that estimates of linear cardiovascular dynamics, i.e., quantifiers 
of the power distribution among frequencies only, are unable to adequately discern healthy subjects from MD 
patients22,43,48–53.
Nonlinear analysis of HRV data, which also quantifies nonlinear interactions among frequencies reflecting 
underlying ANS dynamics, represents a recent frontier in the assessment of psychiatric disorders. In this context, 
nonlinear measures have already allowed the discrimination of depressive patients from healthy subjects, consist-
ently showing a significant decrease of complexity in the pathological cohort22,49–51. These findings support the 
hypothesis that complexity of physiologic signals could be used as dynamical biomarkers of depression.
HRV Assessment in Post Traumatic Stress Disorder with Insomnia. Sleep disturbances and insom-
nia related to post-traumatic stress disorder (PTSD) are a prototypical example of the comorbidity between auto-
nomic dysfunction psychological distress. Among American adults, the estimated lifetime prevalence of PTSD is 
6.8%54. Sleep disturbances such as insomnia and nightmares have much higher prevalence (up to 60%) in people 
with PTSD compared to those without PTSD55. As separate conditions, both PTSD and insomnia are character-
ized by chronic hyperarousal of Autonomic Nervous System (ANS) activity56, i.e., high sympathetic and hypotha-
lamicpituitaryadrenal activity), and drug-nave subjects with PTSD display decreased cardiac vagal control when 
compared to subjects without PTSD and matched controls57. Clinically, this overlap is reflected in an entire cluster 
of the DSM-IV-TR diagnostic criteria for PTSD pertaining to hyperarousal58. Accordingly, the DSM-IV-TR PTSD 
hyperarousal cluster includes assessment of insomnia symptoms, and autonomic dysregulation has also been 
proposed as an important mechanism in the pathogenesis of insomnia59. While we are not aware of literature 
on ANS function in PTSD-related insomnia, one study suggested the existence of a relationship between sleep 
disturbances and baroreceptor sensitivity in women with PTSD60.
Among the approaches thought to aid in stress reduction and the prevention of mental disorders, yoga has 
been seen to be an effective strategy61. Mixed evidence suggests that yoga influences HRV dynamics in people 
without PTSD, including advanced yoga practitioners as well as adults exposed to acute trauma and chronic 
stress62–64. While some studies have shown that yoga reduces psychological symptoms in PTSD, no studies have 
directly investigated HRV dynamics in PTSD patients (with or without insomnia) who practice yoga65,66. Because 
insomnia and PTSD involve ANS dysregulation, and because yoga may balance ANS function, HRV analysis has 
the potential to serve as a biomarker to assess the therapeutic effect of yoga in reducing hyperarousal in PTSD.
HRV Assessment in Parkinson’s Disorders. Parkinson’s disease (PD) is the second most common neu-
rodegenerative disorder after Alzheimer’s disease, and is classically associated with motor symptoms including 
tremor, balance problems, limb rigidity, bradykinesia and gait abnormalities67. The causes and aetiology of this 
disease are still largely unknown. Symptoms of ANS failure are known to be part of the disease68. They include 
cardiovascular, sexual, bladder, gastrointestinal, and sudo-motor abnormalities69, and previous studies reported 
a variable prevalence of cardiovascular autonomic dysfunction between 23% and 80%70,71.
HRV measures have been employed to non-invasively explore ANS alterations in PD by evaluating the mod-
ulatory effects of ANS dynamics on sinus node activity72. In one of these studies, all HRV spectral components 
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(calculated from studying 24 h outpatient ECG recordings) were found to be significantly lower in the PD patients 
when compared to control subjects73. In another study on 10 minutes of data recorded at rest, HRV-HF power 
was significantly lower in untreated patients with PD with respect to healthy controls, whereas nonlinear HRV 
analysis based on entropy and geometrical measures was not able to distinguish between patients and controls74. 
However, PD patients displayed an increase in complexity of systolic arterial pressure series when compared to 
controls75. Taken together, these findings point towards a possible role of HRV analysis characterizing subtle 
autonomic alterations which accompany major motor symptoms in PD.
Experimental Setup and Results
In order to validate the complexity variability framework, in this paper we pooled four experimental data-
sets involving cardiovascular, neurological, and mental disorders such as Congestive Heart Failure (CHF), 
Major Depression Disorder (MDD), Parkinsonos Disease (PD), and Post-Traumatic Stress Disorder (PTSD) 
with insomnia. Within the CHF, MDD, and PD datasets the patient population was compared with age- and 
gender-matched healthy controls. In the PTSD dataset, we performed paired comparison of data gathered before 
and after all patients underwent yoga practice training. Details on each experimental setup follow below.
All features were instantaneously calculated with a δ = 5 ms temporal resolution from each recording of each 
subject. KS and autocorrelation plots were visually inspected to check that all points of the plot were within 
the 95% of the confidence interval, hence guaranteeing the independence of the model-transformed intervals76. 
NARL model order selection was performed by choosing orders that minimize KS distances (the smaller the KS 
distance, the better the model fit). Once the order p,q is determined, the initial NARL coefficients are estimated 
by the method of least squares76. Accordingly, our analysis indicated p = 3~5 and q = 1~3 with α = 0.2 as optimal 
choice.
Complex Dynamics in Congestive Heart Failure patients. This dataset was selected from data gathered 
from CHF patients and reference healthy subjects on a public source: Physionet (http://www.physionet.org/)77. 
All participants received information about the study procedures and gave written informed consent approved by 
the local Institutional Review Board. The experimental protocol was approved by the Hospitals’ Human Subjects 
Committees. Data were acquired in accordance with the approved guidelines78. RR time series were recorded 
from 14 CHF patients (from BIDMC-CHF Database) as well as 16 healthy subjects (from MIT-BIH Normal Sinus 
Rhythm Database). Each RR time series, extracted from the 20 h recording at the same day cycle, was artifact-free 
(upon visual inspection and artifact rejection based on the point-process model79) and lasted about 50 min. These 
recordings have been employed in multiple landmark studies of complex heartbeat interval dynamics7,8,12,15,27,80.
Results. In this dataset, we tested the ability of instantaneous linear and complex nonlinear estimates of heart-
beat dynamics to discriminate healthy subjects from CHF patients. Exemplary instantaneous tracking of complex 
heartbeat dynamics, along with the first-order moment, are shown in Fig. 1. Group statistics are reported in 
Table 1. The difference was expressed in terms of p-values calculated through a non-parametric Mann-Whitney 
test under the null hypothesis that the medians of the two sample groups were equal.
On average, CHF patients show significantly lower μRR, σRR, as well as lower LF and HF power. The median 
IDLE (IDLE) was not significantly different between the two groups. Conversely, the complexity variability meas-
ure, CVIDLE, showed significant statistical difference (p < 0.05). It is worth noting that we detected an increase 
Figure 1. Instantaneous heartbeat statistics computed using a NARL model from a representative CHF 
patient (top panels) and healthy subject (bottom panels). Estimated μRR(t) and IDLE series are reported.
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in CVIDLE in the pathological state (as compared to controls), contrarily to classical nonlinear-based assess-
ments7,8,23,31–33,38, in which pathology is consistently associated with a decrease of complexity. Our novel quantifier 
therefore provides an additional dimension associated with incremental knowledge about changes in cardiovas-
cular complexity in CHF7,8,23,31–33,37,38.
Complex Dynamics in Major Depression Disorder Patients. 48 outpatients (age: 22.6 ± 4.7 years) 
with Major Depression Disorder (MDD) were recruited through screening in a population of University stu-
dents by applying the Zung-self-rating depression scale81. All patients were experiencing their first MDD epi-
sode and had not received psychotherapeutic or pharmacological treatment. A control group consisting of 48 
age- and gender-matched healthy subjects was also included (age: 23.5 ± 4.9 years). Sixteen men (33.3%) and 
32 women (66.6%) were included in each group. Exclusion criteria for both MDD and healthy subjects were: 
cardio-, cerebro-, or peripheral vascular diseases, the presence of neoplasm, diabetes mellitus, kidney or liver 
failure, infectious or systemic inflammatory disease and current neurological illnesses. All participants received 
information about the study procedures and gave written informed consent approved by the local Institutional 
Review Board of the Cardiovascular Foundation of Colombia, Bucaramanga, Colombia. The experimental pro-
tocol was approved by such ethical committee. Data were acquired in accordance with the approved guidelines. 
Participants abstained from smoking or consuming beverages containing caffeine, xanthines or alcohol the day 
before evaluation. Continuous ECG monitoring (lead II) was performed with a Finometer device (Finapress 
Medical System, The Netherlands) while subjects were asked to rest for 10 minutes in a reclining position. Further 
details can be found in ref. 51.
Results. Exemplary instantaneous tracking of complex heartbeat dynamics, along with the first-order moment, 
during 10 minutes of resting state are shown in Fig. 2. Group statistics are reported in Table 2. The difference was 
CHF Healthy p-value
μRR(ms) 654.77 ± 61.8 863.8 ± 53.7 < 4e−4
σRR(ms) 8.12 ± 2.0 23.7 ± 7.2 < 7e−4
LF(ms2) 28.78 ± 19.1 507.3 ± 204.7 < 3e−5
HF(ms2) 40.29 ± 31.6 627.0 ± 408.2 < 1e−3
Balance 0.72 ± 0.4 1.12 ± 0.7 > 0.05
IDLE 0.0014 ± 0.0649 0.0135 ± 0.0368 > 0.05
CVIDLE 0.0595 ± 0.0120 0.0476 ± 0.0066 < 0.05
Table 1.  Group Statistics of Features from healthy and CHF subjects. p-values are obtained from the Mann-
Whitney test between the CHF and healthy subject groups.
Figure 2. Instantaneous heartbeat statistics computed from a representative MDD patient (top panels) and 
healthy subject (bottom panels) using a NARL model. Estimated μRR(t) and IDLE series are shown along a 
10 minutes of resting state.
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expressed in terms of p-values from a non-parametric Mann-Whitney test under the null hypothesis that the 
medians of the two sample groups are equal.
In summary, in presence of a severe depressive state CVIDLE provides significant statistical power in discern-
ing MDD from healthy subjects. To our knowledge, this is the first time that a time-varying complexity assess-
ment is proposed in mental disorders. Our results are also in agreement with previous studies demonstrating 
that estimates of linear cardiovascular dynamics are unable to adequately discern healthy subjects from MD 
patients22,43,48–53. Also, as in CHF (see above), classical complexity measures have been seen to decrease in MDD 
when compared to healthy controls48,49,53. In this study, we show that our CVIDLE measure is significantly increased 
in MDD as compared to controls, hence providing additional information about complex cardiovascular changes.
Complex Dynamics in Post-Traumatic Stress Disorder with Insomnia and Yoga Training. The 
overall objective of this experimental setup was to evaluate the potential of yoga as an adjunctive treatment for 
insomnia related to PTSD. Nineteen adults (over 18 years-old) were recruited to participate in this study. Insomnia 
and PTSD unrestricted by trauma history was confirmed in study participants using the Clinician-Administered 
PTSD Scale and the American Academy of Sleep Medicine’s Research Diagnostic Criteria for insomnia related 
to a mental health disorder82,83. All participants received information about the study procedures and gave writ-
ten informed consent approved by the local Institutional Review Board (Partners Human Research Committee, 
Brigham and Women’s Hospital, Boston, MA, USA) The experimental protocol was approved by the Institutional 
Review Board. Data were acquired in accordance with the approved guidelines. Participants were asked to con-
tinue any other stable treatments they were on (pharmacological and behavioral) 6 weeks from baseline through-
out the duration of the study. Also, all subjects were naive to yoga (< 1 hour/week in the past 6 months). The 
intervention consisted of an 8-week, closed-group yoga program: classes met twice weekly for 90 minutes, with 
15-minute personal practice on non-class days guided by DVD or online. This manualized program included eth-
ics, postures, breath regulation, relaxation and basic meditation techniques taught in the Kripalu yoga style. The 
first 4 weeks focused upon learning all techniques except meditation, while building safety and trust; the second 
half involved more time in poses and breaths, and introduced meditation. Continuous ECG data was collected at 
baseline and at end of treatment 5 minutes of resting state with regular breathing. Out of the 19 participants who 
completed the study (50% attrition), 12 had evaluable baseline and end-treatment ECG data.
Results. Instantaneous linear and complex nonlinear estimates of heartbeat dynamics were used to investigate 
significant changes in ANS activity between before- and after-performing the yoga training. Exemplary instanta-
neous tracking of the complex heartbeat dynamics, along with the first-order moment are shown in Fig. 3. Paired 
group statistics are reported in Table 3. The difference was expressed in terms of p-values from a non-parametric 
Wilcoxon test under the null hypothesis that the medians of the two paired sample groups are equal.
In particular, in PTSD patients who improved their mental well-being by decreasing their psychological dis-
tress after yoga training (e.g., PTSD symptoms decreased with p < 0.005 from 57.1 ± 2.5 at baseline to 46.8 ± 2.9 
based on the PTSD Checklist - Specific for the Diagnostic and Statistical Manual for Mental Health Disorders, 
4th edition; from Noggle et al., in preparation), our complexity variability measure was significantly lower when 
comparing data acquired before and after training. To our knowledge, estimates of CVIDLE are able for the first 
time to provide an effective quantification of improved mental well-being employing exclusively cardiovascular 
dynamics.
Complex Dynamics in Parkinson’s Disease. Cardiovascular signals were recorded from 29 healthy con-
trols (HC, 18 males) and 30 PD patients (23 males). Subjects were placed horizontally in a supine position and 
remained at rest during the whole recording (10 minutes). During the acquisition, all subjects were instructed 
not to talk and maintained relaxed spontaneous breathing. All participants gave written informed consent to 
participate in the study, which was approved by the Versilia Hospital, AUSL 12 Viareggio, Lido di Camaiore (LU), 
Italy, committee. The experimental protocol was approved by the local ethics committee. Data were acquired in 
accordance with the approved guidelines. Clinical assessment included history of disease-related symptoms and 
signs, and full neurological examination. All patients were screened for cardiovascular autonomic dysfunction 
which was considered as exclusion criterion. All patients had to satisfy the UK Brain Bank criteria for the diag-
nosis of PD84 and were in stage 1, 1.5 2 or 2.5 according to the Hoehn-Yahr (HY) system. As supportive criterion, 
MDD Healthy p-value
μ RR(ms) 932.96 ± 53.96 921.90 ± 72.57 > 0.05
σRR
2 (ms2) 1310.70 ± 756.63 958.06 ± 547.60 > 0.05
LF(ms2) 854.35 ± 672.67 742.52 ± 406.91 > 0.05
HF(ms2) 1120.38 ± 645.29 906.98 ± 605.64 > 0.05
Balance 0.76 ± 0.35 0.78 ± 0.49 > 0.05
IDLE 0.035735 ± 0.0405 0.0247  ± 0.0418 > 0.05
CVIDLE 0.080021 ± 0.0164 0.0694 ± 0.0149 < 0.03
Table 2.  Group Statistics of Features from the MDD dataset. p-value are from the Mann-Whitney non-
parametric test with null hypothesis of equal medians. No significant difference was found in any feature except 
in our novel heartbeat complexity variability index CVIDLE.
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a 123IFP-CIT SPECT to confirm nigrostriatal degeneration was performed. Severity of parkinsonism was evalu-
ated by the Unified Parkinsonos Disease Rating Scale (UPDRS)85 and the HY staging system86.
Results. In this case, we tested the ability of instantaneous linear and complex nonlinear estimates of heartbeat 
dynamics in discriminating healthy subjects from PD patients. Exemplary instantaneous tracking of the complex 
heartbeat dynamics, along with the first-order moment, during 10 minutes of resting state are shown in Fig. 4. 
Group statistics are reported in Table 4 (reproduced from28 with permission). The difference was expressed in 
terms of p-values from a non-parametric Mann-Whitney test under the null hypothesis that the medians of the 
two sample groups are equal.
Importantly, our results suggest that PD states are associated with an increase of complexity variability, pos-
sibly pointing toward subtle autonomic changes which may accompany or precede autonomic dysfunctions, and 
can only be detected using an instantaneous, time resolved approach to quantifying autonomic complexity.
Figure 3. Instantaneous heartbeat statistics computed using a NARL model from a representative PTSD 
patient before (top panels) and after (bottom panels) performing a yoga training. Estimated μRR(t) and IDLE 
series are reported.
Before Yoga After Yoga p-value
μRR(ms) 807.27 ± 38.37 789.14 ± 76.85 > 0.05
σRR
2 (ms2) 207.52 ± 152.96 679.96 ± 601.31 > 0.05
LF(ms2) 573.87 ± 325.02 496.80 ± 274.64 > 0.05
HF(ms2) 213.79 ± 188.52 484.13 ± 459.82 > 0.05
Balance 2.52 ± 1.82 3.14 ± 2.47 > 0.05
IDLE − 0.0369 ± 0.0441 0.0036  ± 0.0486 > 0.05
CVIDLE 0.0602 ± 0.0139 0.0358 ± 0.0107 < 0.02
Table 3.  Group Statistics of Features from PTSD before and after Yoga training. p-values are from the 
Wilcoxon non-parametric test for paired data with null hypothesis of equal medians. No significant difference 
was found in any feature except in our novel heartbeat complexity variability index CVIDLE.
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Discussion and Conclusion
We presented a novel complexity variability framework for the assessment of complex physiological dynamics. 
This work was motivated by the fact that a single complexity estimation, which collapses data across time, may 
not be sufficient to completely characterize physiological system complexity in the face of non-stationary behav-
ior20–23. Importantly, accounting for temporal dynamics of stochastic events is fundament for the assessment of 
complex ecosystems, too87,88.
Our methodological approach is based on the time-varying assessment of Lyapunov exponents (e.g. the IDLE 
index) within a point-process paradigm which has been explicitly devised for modeling cardiovascular control. 
We performed instantaneous IDLE estimates in four exemplary datasets, involving data gathered in patients with 
cardiovascular disease such as CHF, as well as in neurological and psychiatric disorders such as MDD, PTSD with 
insomnia, and Parkinson’s Disease (PD). The time-varying IDLE information was summarized through measures 
of central tendency (median value) and variability (median absolute deviation).
In all statistical comparisons of patients vs controls or patients before treatment vs patients after treatment, 
the central tendency of complexity measures did not show any significant differences. Conversely, our complexity 
variability measures always showed statistically significant differences. Moreover, when compared to other instan-
taneous heartbeat estimates defined in the time and frequency domains76, only heartbeat complexity variability 
measures showed significant differences in the MDD, PTSD and insomnia treatment, and PD datasets.
Of note, in the attempt to provide a plausible comparison set, we were not able to find high time-resolution 
indices that were going beyond the standard heart rate variability indices (linear and nonlinear). Reasonably, we 
do not exclude that other indices derived by processing series of heartbeat dynamics might present meaningful 
characteristics able to effectively discern between, e.g., healthy control subjects and patients with major depres-
sion, Parkinson’s disease, congestive heart failure, or post traumatic stress disorder. Indeed, we aimed to study 
clinically meaningful, statistical properties of complexity variability, i.e., of the variance of a series quantifying the 
complexity level of a nonlinear system.
Figure 4. Instantaneous heartbeat statistics computed using a NARL model from a representative PD 
patient (top panels) and healthy subject (bottom panels) during 10 minutes of resting state. Estimated μRR(t) 
and IDLE series are reported.
PD Healthy p-value
μRR(ms) 915.5 ± 71.9 918.3 ± 101.2 > 0.05
σRR
2 (ms2) 203.64 ± 104.84 272.46 ± 117.84 > 0.05
LF(ms2) 184.20 ± 119.13 176.27 ± 108.93 > 0.05
HF(ms2) 121.64 ± 50.50 141.44 ± 78.20 > 0.05
Balance 1.27 ± 0.80 1.26 ± 0.61 > 0.05
IDLE − 0.004 ± 0.027 − 0.034  ±  0.035 > 0.05
CVIDLE 0.0796 ± 0.0140 0.0596 ± 0.0136 < 0.05
Table 4.  Statistical analysis between PD and healthy groups. p-value are from the Mann-Whitney non-
parametric test with null hypothesis of equal medians. No significant difference was found in any feature except 
in our novel heartbeat complexity variability index CVIDLE.
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While the findings reported in this study will need further characterization before they can be directly trans-
lated into clinical practice, the presence of significant differences in complexity variability measures between 
MDD, PTSD and insomnia treatment, provides an indication that these physiological measurements could poten-
tially aid in the early differential diagnosis between subjects experiencing normal grief or anxiety symptoms and 
those eventually evolving to clinical depression or PTSD in response to a stressful life event. This is of particular 
importance for clinical practitioners, given that normal grief, although sharing similar clinical symptoms with 
depression, neither involves the physiological alterations reported in MDD nor requires pharmacological inter-
ventions. Furthermore, consistently detecting altered autonomic features could provide an indication of how the 
modulation of peripheral physiology by cortical and subcortical pathways becomes disrupted during active MDD 
and PTSD. The study of complex ANS activity could therefore potentially be explored as an early physiological 
index for remission or relapse in patients under treatment. Interestingly, in the case of cardiovascular and mental/
neurological disorders, complexity variability measures were significantly higher in the pathological groups as 
compared to controls (healthy subjects). Consistent with these findings, in case of PTSD patients who improved 
their mental well-being, complexity variability measures were significantly lower when comparing data acquired 
before and after yoga training. Additionally, we found an increased complexity variability in PD patients when 
compared to controls. While the etiology of ANS disturbances in PD (also known as dysautonomia) are not 
yet well-understood, it is known that they reflect neurodegenerative processes which involve additional circuits 
apart from the nigrostriatal dopaminergic system89,90, and develop in a manner which is largely independent of 
the evolution of dopaminergic symptoms. Accordingly, it has been shown that the assessment of cardiovascular 
autonomic failure can aid in early recognition and treatment of PD91,92, and previous studies have demonstrated 
parkinsonisms such as Multiple System Atrophy and Progressive supranuclear palsy display different patterns 
of disease-related alterations with respect to PD93,94. A better understanding, early recognition and treatment of 
ANS failure in PD may therefore aid in the differential diagnosis of Parkinsonisms as well as have an impact on 
patient management quality and therefore quality of life. In this context, currently the evaluation of ANS dysfunc-
tions relies on combersome diagnostic tests only available in selected centers93–95 and it is associated with a large 
amount of diagnostic and financial overhead. We have shown that additional measures related higher-order, com-
plexity statistics of heartbeat dynamics as well as from their variability over time are the most useful in discrimi-
nating PD patients from controls, possibly pointing towards their employment in a lightweight (i.e., ECG-based 
only) and therefore more widespread diagnostic environment.
Therefore, overall, opposite to the common concept that cardiovascular variability decreases with disease, we 
have found a measure of variability that increases in the presence of some pathological states, and decreases with 
states of mental well-being.
Taken together, these evidences suggest that our Lyapunov-based, heartbeat complexity variability measures 
could be employed as a putative biomarker of psychiatric and/or neurological well-being, where higher complex-
ity variability is associated with a more severe pathological state. In addition, complexity variability might allow 
for better stratification of pathological subtypes, providing an additional discriminant dimension in building a 
feature space. These findings are in agreement with the current literature which posits that cardiovascular dis-
orders affect complexity and variability1,9–16. On the methodological side, it is important to mention that our 
IDLE estimates are not affected by the intrinsically discrete nature of heartbeat dynamics, which are unevenly 
spaced in time. Additionally, our IDLE estimates are independent of signal background noise statistics7,8, which 
have been seen to heavily confound the detection of disease-related alterations in complexity24. Of note, we used 
discrete Laguerre expansions on cubic autoregressive Wiener-Volterra models to achieve long-term memory and 
improved performances in parameter estimation, as confirmed by goodness of fit measures7.
Also, unlike other methods that might require relatively long-term recordings, our method is potentially 
useful to obtain complexity measures from short recordings. Future work will investigate the potential of these 
time-varying complexity estimates in producing new real-time measures for the underlying complexity of phys-
iological systems.
Methods for Cardiovascular Complexity Variability Estimation
In this section, details on the signal processing methodology for the cardiovascular complexity variability estima-
tion are reported. A summary of all indices used in this study is reported in Table 5.
Lyapunov Exponents Estimation. The Lyapunov Exponent (LE) of a real valued function f(t) defined for 
t > 0 is ref. 96:
λ =
→∞ t
f tlimsup1 log( ( ) ) (1)t
More generally, let us consider n-dimensional linear system in the form yi = Y(t)pi, where Y(t) is a fundamental 
solution matrix with Y(0) orthogonal, and {pi} is an orthonormal basis of n. Then, the sum of the corresponding 
n Lyapunov Exponents (λi) is minimized, and the orthonormal basis {pi} is called “normal”96. One of the key 
theoretical tools for determining LEs is the continuous QR factorization: Y(t) = Q(t)R(t)97,98 where Q(t) is orthog-
onal and R(t) is upper triangular with positive diagonal elements Rii, i = 1:n. Therefore we obtain96–98:
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Considering N data samples, we evaluate the Jacobian over the time series, and determine the LE by means of 
the QR decomposition:
= = ... .−J n Q Q R n N( ) with 1,2 ,n n n( 1) ( ) ( )
This decomposition is unique except in the case of zero diagonal elements. Then, leveraging on the estimation 
of the matrices R(n), the LEs λi are given by
∑λ τ= =
−
N
R1 ln
(3)i n
N
n ii
0
1
( )
where τ is the sampling time step, and R(n)ii is the value in the diagonal taken by the ith row and ith column.
Nonlinear Modeling of History Dependence. The expected value of a nonlinear autoregressive model 
can be written as follows:
∑ ∑ ∑ ∑ ∏γ γ γ= + − + … … −
= =
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Due to the autoregressive structure of (4), the system can be identified with only exact knowledge of the out-
put data and with only few assumptions on the input data.
An important practical limitation in modeling high-order nonlinearities using the model in (4) is the high 
number of parameters that need to be estimated from the observed data. An advocated approach to solve such 
a limitation is the use of Laguerre functions99–102. Let us define the jth-order discrete time orthonormal Laguerre 
function:
∑φ α α α α= − −





 −
−
=
−( )n ni ji( ) (1 ) ( 1) (1 ) ,j
n j
i
j
i j i i2
1
2
0
where α is the discrete-time Laguerre parameter (0 < α < 1) which determines the rate of exponential asymp-
totic decline of these functions, and n ≥ 0. Given the Laguerre function, φj(n), and the signal, y(n), the jth-order 
Laguerre filter output is:
∑φ= − −
=
∞
l n i y n i( ) ( ) ( 1)
(5)j i
j
0
Time-Varying Modeling of Heartbeat Intervals. The iterative estimation along time of the time-varying 
complexity and related complexity variability index can be performed using several signal processing methods. 
For example, traditional recursive least-square and window-based methods can be applied. In addition, a simple 
Kalman filtering can be used to track the complex cardiovascular dynamics at each heartbeat, whereas an instan-
taneous estimation (i.e., at each moment in time) can be performed using point-process modeling.
A random point process is a stochastic process whose elements are point patterns specified as a locally finite 
counting measure103. Considering the R-waves detected from the Electrocardiogram (ECG) as such events, point 
Feature Symbol Description Meaning References
μRR Mean of the Inverse-Gaussian pdf Instantaneous Mean of the RR Interval Series 15,76
σRR
2 Variance of the Inverse-Gaussian pdf Instantaneous Standard Deviation of the RR Interval Series 15,76
LF Low-Frequency Power of the RR interval series spectrum
Instantaneous Sympathetic and 
Parasympathetic Activity 15,76
HF High-Frequency Power of the RR interval series spectrum Instantaneous Parasympathetic Activity 15,76
Balance Ratio between Low- and High-Frequency Power of the RR interval series spectrum Instantaneous Sympatho-Vagal Balance 15,76
IDLE Dominant (First) Lyapunov Exponent of the RR interval series Measure of Instantaneous Complexity 7
CVIDLE Variance of the IDLE of the RR interval series Measure of Complexity Variability 7
Table 5.  A summary of all features used in this study.
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process theory can be used to characterize their probability of occurrence76,104–107. Mathematically, in the time 
domain, a simple 1-D point process consists of series of timestamps marking the occurrence times t ∈ [0,∞ ) of 
the random events. Given a set of R-wave events =u{ }j j
J
1, let RRj = ujuj−1 > 0 denote the jth R–R interval, or equiv-
alently, the waiting time until the next R-wave event. Assuming history dependence, the probability distribution 
of the waiting time tuj until the next R-wave event, where uj denotes the previous R-wave event occurred before 
time t, follows an inverse Gaussian (IG) model:
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where  = ...− − +u RR RR RR( , , , , )t j j j j M1 1  is the history of the point process, ξ(t) is the vector of the 
time-varing parameters, µ ξt t( , , ( ))RR t  represents the first-moment statistic (mean) of the distribution, and 
ξ0(t) = θ > 0 denotes the shape parameter of the IG distribution (as θ/μ → ∞ , the IG distribution becomes more 
like a Gaussian distribution). As  ξf t t( , ( ))t  indicates the probability of having a beat at time t given that a 
previous beat has occurred at uj, its first moment µ ξt t( , , ( ))RR t  can be interpreted as the average (or expected) 
waiting time before the next beat. We can also estimate the second-moment statistic (variance) of the IG distribu-
tion as σ µ θ=t t( ) ( )/RR RR
2 3 . The use of an IG distribution to characterize the R-R intervals is physiologically moti-
vated: if the rise of the membrane potential to a threshold initiating the cardiac contraction is modeled as a 
Wiener process with drift, then the probability density of the times between threshold crossings (the RR intervals) 
is indeed the inverse Gaussian distribution76. It is important to note that, when compared with other distribu-
tions, the IG model always achieves the best fitting results105. The instantaneous RR mean, µ ξt t( , , ( ))RR t , can 
be modeled as a generic function of the past RR values µ ξ = ...− − −t t g RR RR RR( , , ( )) ( , , , )RR t j j j h1 2 , where 
RRj−k denotes the previous kth R–R interval occurred prior to the present time t.
Here, we represent the nonlinear cardiovascular system by modeling the instantaneous RR mean within a 
inhomogeneous point-process modeling, taking into account up to the cubic nonlinear terms:
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hereinafter called Nonlinear Autoregressive with Laguerre expansion (NARL) model, with g0,{g1(i)}, {g2(i,j)}, and 
{g3(i,j,k)} the Laguerre coefficients7,15.
When α = 0 the filter output becomes lj(n) = (− 1)jy(n − j − 1) and the NARL model corresponds, apart for the 
sign, to the finite nonlinear autoregressive model (NAR) model in (4), whereas for α ≠ 0 the instantaneous RR 
mean is theoretically defined as follows:
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thus having long-term (infinite) memory, and ∆ = −− − −∼ ∼RR (RR RR )h N t h N t h( ) ( ) 1 . The use of the derivative RR 
series is aimed at improving model fits in highly non-stationary environments108.
Moreover, using the point-process modeling, as µ ξt t( , , ( ))RR t  is defined in a continuous-time fashion, we 
can obtain an instantaneous R–R mean estimate at a very fine timescale (with an arbitrarily small bin size Δ ), 
which requires no interpolation between the arrival times of two beats. Given the proposed parametric model, the 
nonlinear indices of the HR and HRV will be defined as a time-varying function of the parameters ξ(t) = [θ(t), 
g0(t), g1(0, t),..., g1(P, t), g2(0, 0, t),..., g2(Q, Q, t), g3(0, 0, 0, t),..., g3(K, K, K, t)].
A local maximum likelihood method76,109,110 is used to estimate the time-varying parameter set x(t). We use 
a Newton-Raphson procedure to maximize the local log-likelihood and compute the local maximum-likelihood 
estimate of x(t)109. Because there is significant overlap between adjacent local likelihood intervals, we start the 
Newton-Raphson procedure at t with the previous local maximum-likelihood estimate at time t − Δ in which Δ 
define how much the local likelihood time interval is shifted to compute the next parameter update. We deter-
mined the optimal orders {p,q,k} using the Kolmogorov-Smirnov (KS) statistic in the post hoc analysis76.
Calculation of the Complexity Variability Index. In our case, the matrix Y(t), described in section 5, 
corresponds to the Jacobian of the j-dimensional system of the NARL model parameters, where j is the value of 
the largest lag in the model6. Therefore, given the NARL model reported in (7) and using proper transformations7, 
it is possible to obtain an M-dimensional state space canonical representation:
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where F(⋅ ) arises directly from (8).
The estimation of the LEs is performed at each time t from the corresponding time-varying vector of parame-
ters, ξ(t). We define the first LE (λ1(t)) as the instantaneous dominant Lyapunov exponent (IDLE). In this paper, 
starting from each IDLE series, the time-varying information was condensed by means of the central tendency 
of the feature distribution, quantified as median (IDLE). In addition, we used the Median Absolute Deviation 
(MAD) with MAD(X) = |X − Median(X)|), of the IDLE to define the complexity variability index CVIDLE.
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